HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Studies in a phenotypic female with 17-alpha-hydroxylase deficiency.

Abstract
In a 19-year-old phenotypic female (46, XY) with hypertension and hypokalemia, studies confirmed 17-alpha-hydroxylase deficiency. Prior to diagnosis she had been considered to have testicular feminization. Increased plasma progesterone and urinary pregnanediol levels were present before treatment. Increased secretion rates of deoxycorticosterone and corticosterone and abnormally low production of cortisol and aldosterone were present. Following treatment with hydrocortisone, plasma progesterone, serum potassium, and urinary pregnanediol levels and DOC and B secretions were normal. Aldosterone secretion six months after treatment remained low. Normal blood pressure measurements were achieved during treatment with hydrocortisone and oral estrogen with the patient at rest; however, mild elevations in blood pressure (130/90 mm Hg) have been noted despite continued hydrocortisone therapy.
AuthorsA K Kershnar, D Borut, M D Kogut, E G Biglieri, M Schambelan
JournalThe Journal of pediatrics (J Pediatr) Vol. 89 Issue 3 Pg. 395-400 (Sep 1976) ISSN: 0022-3476 [Print] United States
PMID182944 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Estrogens, Conjugated (USP)
  • Aldosterone
  • Progesterone
  • Steroid Hydroxylases
  • Pregnanediol
  • Potassium
  • Corticosterone
  • Hydrocortisone
Topics
  • Adult
  • Aldosterone (biosynthesis)
  • Androgen-Insensitivity Syndrome
  • Blood Pressure (drug effects)
  • Corticosterone (metabolism)
  • Estrogens, Conjugated (USP) (pharmacology)
  • Female
  • Humans
  • Hydrocortisone (biosynthesis, pharmacology)
  • Phenotype
  • Potassium (blood)
  • Pregnanediol (blood)
  • Progesterone (blood)
  • Steroid Hydroxylases (deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: